CME Information

Intended Audience

This continuing medical education (CME) activity is developed for pediatricians, neonatologists and other health care professionals involved in the care of children.

Learning Objectives

At the conclusion of this activity, attendees will be able to:

  • List the four pillars for using an exclusive human milk diet in premature neonates.
  • State the importance of ensuring the safety and quality of donor human milk.
  • Develop a strategy for optimal use of human milk-based human milk fortifier for neonates in the NICU.
  • Recognize that independent clinical trials support the clinical benefits to neonates of an exclusive human milk diet for the reduction of NEC and NEC surgery.
  • Explain how the relatively rapid spread of the exclusive human milk diet may explain some of the decline in NEC reported in the Vermont-Oxford Network (VON) database.
  • List the short-term benefits of administering human milk-based fortified human milk to neonates (in addition to the reduction of NEC and NEC surgery).
  • Identify the long-term benefits of an exclusive human milk diet as measured by neurodevelopmental improvements and cardiovascular effects in neonates.


During this symposium, experts in the care of premature neonates will collate and interpret the evidence of benefits of an exclusive human milk diet to optimize outcomes during the nutritional care of neonates in the NICU. The four pillars supporting an exclusive human milk diet in premature neonates will be presented as follows:

  1. Early concerns over safety and efficacy of human milk-based human milk fortifier have been successfully addressed as a result of improved collecting and screening techniques. Safe collection and screening of mother's milk complemented by good manufacturing processes are essential.
  2. Insights will be provided on the short-term benefits of human milk-based human milk fortifier in clinical practice.
  3. Discussion of what has been learned about human milk-based fortifier beyond NEC to maximize short-term benefits in the NICU
  4. Data on long-term benefits, including neurodevelopmental improvements and cardiovascular effects.

Clinicians attending this program will learn about the benefits of an exclusive human milk diet in their VLBW premature neonates.


There is no fee to participate in this activity.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Dannemiller and continuED Medical.

Dannemiller is accredited by the ACCME to provide continuing medical education for physicians.

Dannemiller designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Alan Lucas, MD (Chair)
Professor, Chair in Paediatric Nutrition
Child Nutrition Research Centre, Institute of Child Health
London, UK

Cynthia L. Blanco, MD
Associate Professor of Pediatrics
University of Texas, San Antonio
San Antonio, Texas, USA

Barry T. Bloom, MD
Professor, Department of Pediatrics - Neonatal-Perinatal Medicine
University of Kansas School of Medicine-Wichita
Wichita, Kansas, USA

Amy B. Hair, MD
Assistant Professor, Section of Neonatology, Department of Pediatrics, Baylor College of Medicine
Program Director, Neonatal Nutrition Program, Texas Children's Hospital
Houston, Texas, USA


In accordance with the Accreditation Council for Continuing Medical Education (ACCME), Dannemiller requires that any person who is in a position to control the content of a CME activity must disclose all relevant financial relationships they have with a commercial interest.

The following faculty members have disclosures to be made:

Alan Lucas: Consultant – Prolacta Bioscience.

Barry T. Bloom: Consultant/Advisory Board, Investigator, Speaker Bureau – ONY, Inc.; Consultant/Advisory Board – HCA.

Cynthia L. Blanco: Investigator, Speaker Bureau – Prolacta Bioscience.

Amy B. Hair: Speaker Bureau – Prolacta Bioscience.

John Russo, PharmD and Toni Nouri, BPharm, continuED Medical content reviewers and Gordon Ringler and Myra Garcia, Dannemiller project managers have no financial relationships with commercial interests.

To resolve identified/potential conflicts of interest, the educational content was fully reviewed by a member of the Dannemiller Clinical Content Review Committee who has nothing to disclose. The resulting certified activity was found to provide educational content that is current, evidence based and commercially balanced.


The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Dannemiller or continuED Medical and Prolacta Bioscience. This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject matter before relying solely upon the information contained within this educational activity.

Americans with Disabilities Act (ADA)

Dannemiller and continuED Medical fully comply with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please contact Toni Nouri at or 510-214-5256 by April 14, 2016 in order to receive service.